Viewing Study NCT07483359


Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-03-30 @ 3:11 AM
Study NCT ID: NCT07483359
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-19
First Post: 2026-03-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus
Sponsor: First Hospital of China Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module